Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo- Controlled Study to Investigate the Efficacy and Safety of Injectafer® (Ferric Carboxymaltose) as Treatment for Heart Failure With Iron Deficiency /and Sub-Study

NCT03037931 is registered in ClinicalTrials.gov with American Regent, Inc. as lead sponsor.

NCT NCT03037931
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03037931 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo- Controlled Study to Investigate the Efficacy and Safety of Injectafer® (Ferric Carboxymaltose) as Treatment for Heart Failure With Iron Deficiency /and Sub-Study
Lead sponsor
American Regent, Inc.
Phase
Phase 3
Overall status
Completed
Start date
March 15, 2017
Completion date
February 2, 2023
Enrollment
3,065 (actual)
Sites
345

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure, iron-deficiency